Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study
Crossref DOI link: https://doi.org/10.1007/s00432-014-1892-z
Published Online: 2014-12-20
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aziz, Faisal
Yang, Xuesong
Wang, Xiaoqi
Yan, Qiu
Text and Data Mining valid from 2014-12-20